Literature DB >> 3123387

Immunological analysis of cell-associated antigens of Bacillus anthracis.

J W Ezzell1, T G Abshire.   

Abstract

Sera from Hartley guinea pigs vaccinated with a veterinary live spore anthrax vaccine were compared with sera from guinea pigs vaccinated with the human anthrax vaccine, which consists of aluminum hydroxide-adsorbed culture proteins of Bacillus anthracis V770-NP-1R. Sera from animals vaccinated with the spore vaccine recognized two major B. anthracis vegetative cell-associated proteins that were either not recognized or poorly recognized by sera from animals that received the human vaccine. These proteins, termed extractable antigens 1 (EA1) and 2 (EA2), have molecular masses of 91 and 62 kilodaltons, respectively. The EA1 protein appeared to be coded by chromosomal DNA, whereas the EA2 protein was only detected in strains that possessed the pXO1 toxin plasmid. Both of the extractable antigen proteins were serologically distinct from the components of anthrax edema toxin and lethal toxin. Following vaccination with the live spore vaccine, the EA1 protein was the predominant antigen recognized, as determined by electrophoretic immunotransblots. Vaccine trials with partially purified EA1 demonstrated that it neither elicits protective antibody against anthrax nor delays time to death in guinea pigs challenged intramuscularly with virulent Ames strain spores. In addition, animals vaccinated with sterile gamma-irradiated cell walls had significant antibody titers to the N-acetylglucosamine-galactose polysaccharide of B. anthracis but were neither protected nor had a delay in time to death following challenge.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123387      PMCID: PMC259287          DOI: 10.1128/iai.56.2.349-356.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Purification of factor I and recognition of a third factor of the anthrax toxin.

Authors:  J L STANLEY; H SMITH
Journal:  J Gen Microbiol       Date:  1961-09

2.  Immunization of cattle against experimental anthrax with alum-precipitated protective antigen or spore vaccine.

Authors:  F C JACKSON; G G WRIGHT; J ARMSTRONG
Journal:  Am J Vet Res       Date:  1957-10       Impact factor: 1.156

3.  [On the terminal groupings of the immuno-specific polysaccharide of Bacillus anthracis].

Authors:  L MESTER; E MOCZAR; G IVANOVICS
Journal:  C R Hebd Seances Acad Sci       Date:  1962-01-29

4.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

5.  Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110 MDa and 60 MDa plasmids.

Authors:  I Uchida; K Hashimoto; N Terakado
Journal:  J Gen Microbiol       Date:  1986-02

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Studies on immunity in anthrax. XI. Control of cellular permeability by bicarbonate ion in relation to protective antigen elaboration.

Authors:  M Puziss; M B Howard
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

8.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

Authors:  A M Friedlander
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

9.  Elaboration of Bacillus anthracis antigens in a new, defined culture medium.

Authors:  J D Ristroph; B E Ivins
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Effects of anthrax toxin components on human neutrophils.

Authors:  J O'Brien; A Friedlander; T Dreier; J Ezzell; S Leppla
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more
  16 in total

1.  Surface-layer (S-layer) proteins sap and EA1 govern the binding of the S-layer-associated protein BslO at the cell septa of Bacillus anthracis.

Authors:  Valerie J Kern; Justin W Kern; Julie A Theriot; Olaf Schneewind; Dominique Missiakas
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

2.  Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide.

Authors:  J W Ezzell; T G Abshire; S F Little; B C Lidgerding; C Brown
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.

Authors:  David Kobiler; Yehoshua Gozes; Hagai Rosenberg; Dino Marcus; Shaul Reuveny; Zeev Altboum
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax.

Authors:  S Cohen; I Mendelson; Z Altboum; D Kobiler; E Elhanany; T Bino; M Leitner; I Inbar; H Rosenberg; Y Gozes; R Barak; M Fisher; C Kronman; B Velan; A Shafferman
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.

Authors:  Mingtao Zeng; Qingfu Xu; Michael E Pichichero
Journal:  Vaccine       Date:  2007-01-26       Impact factor: 3.641

6.  Characterization of the Bacillus anthracis S-layer: cloning and sequencing of the structural gene.

Authors:  I Etienne-Toumelin; J C Sirard; E Duflot; M Mock; A Fouet
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

7.  Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging.

Authors:  Patrick Sanz; Louise D Teel; Farhang Alem; Humberto M Carvalho; Stephen C Darnell; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

8.  Purification and characterization of the major surface array protein from the avirulent Bacillus anthracis Delta Sterne-1.

Authors:  J W Farchaus; W J Ribot; M B Downs; J W Ezzell
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

9.  Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.

Authors:  Y Singh; B E Ivins; S H Leppla
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis.

Authors:  Barun K De; Sandra L Bragg; Gary N Sanden; Kathy E Wilson; Lois A Diem; Chung K Marston; Alex R Hoffmaster; Gwen A Barnett; Robbin S Weyant; Teresa G Abshire; John W Ezzell; Tanja Popovic
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.